Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post-haploidentical allogeneic stem cell transplant.
Anastasia MartynovaAli NaelCaitlin O NeillGiridharan RamsinghAkil MerchantBassam YaghmourGeorge YaghmourPublished in: British journal of haematology (2019)